Intuitive Surgical Inc (ISRG)
547.87
-2.75
(-0.50%)
USD |
NASDAQ |
Nov 22, 16:00
548.60
+0.73
(+0.13%)
After-Hours: 20:00
Intuitive Surgical Cash from Financing (Quarterly): 98.20M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 98.20M |
| June 30, 2024 | 50.00M |
| March 31, 2024 | -46.70M |
| December 31, 2023 | -31.50M |
| September 30, 2023 | 61.80M |
| June 30, 2023 | 63.30M |
| March 31, 2023 | -381.20M |
| December 31, 2022 | -963.50M |
| September 30, 2022 | -926.80M |
| June 30, 2022 | -482.10M |
| March 31, 2022 | -199.90M |
| December 31, 2021 | 18.60M |
| September 30, 2021 | 68.30M |
| June 30, 2021 | 58.30M |
| March 31, 2021 | -102.20M |
| December 31, 2020 | -39.80M |
| September 30, 2020 | 85.20M |
| June 30, 2020 | 47.60M |
| March 31, 2020 | -178.70M |
| December 31, 2019 | 50.80M |
| September 30, 2019 | 1.20M |
| June 30, 2019 | -178.60M |
| March 31, 2019 | -41.80M |
| December 31, 2018 | 33.70M |
| September 30, 2018 | 57.70M |
| Date | Value |
|---|---|
| June 30, 2018 | 43.20M |
| March 31, 2018 | -8.30M |
| December 31, 2017 | -243.10M |
| September 30, 2017 | 83.60M |
| June 30, 2017 | 124.70M |
| March 31, 2017 | -1.878B |
| December 31, 2016 | -4.70M |
| September 30, 2016 | 100.50M |
| June 30, 2016 | 188.50M |
| March 31, 2016 | 230.10M |
| December 31, 2015 | -58.10M |
| September 30, 2015 | 112.40M |
| June 30, 2015 | 38.80M |
| March 31, 2015 | 66.00M |
| December 31, 2014 | 116.40M |
| September 30, 2014 | 94.60M |
| June 30, 2014 | -974.00M |
| March 31, 2014 | 70.60M |
| December 31, 2013 | 29.60M |
| September 30, 2013 | -663.40M |
| June 30, 2013 | -241.00M |
| March 31, 2013 | -35.80M |
| December 31, 2012 | 73.10M |
| September 30, 2012 | -121.90M |
| June 30, 2012 | 64.90M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-963.50M
Minimum
Dec 2022
98.20M
Maximum
Sep 2024
-137.52M
Average
-6.45M
Median
Cash from Financing (Quarterly) Benchmarks
| Abbott Laboratories | -1.576B |
| Becton Dickinson & Co | 124.00M |
| Masimo Corp | -1.60M |
| PROCEPT BioRobotics Corp | 1.715M |
| Perspective Therapeutics Inc | 0.628M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 706.50M |
| Cash from Investing (Quarterly) | -1.413B |
| Free Cash Flow | 586.00M |
| Free Cash Flow Per Share (Quarterly) | 1.264 |
| Free Cash Flow to Equity (Quarterly) | 458.60M |
| Free Cash Flow to Firm (Quarterly) | 458.60M |
| Free Cash Flow Yield | 0.30% |